Business
First Human Dose in Phase 1 Clinical Trial of AMP945
First Human Dose in Phase 1 Clinical Trial of AMP945
About this update from Amplia Therapeutics Ltd.
[{"type":"text","content":"Amplia Therapeutics Ltd has released a press release. View Attachment","length":243,"tagName":"div"}]